The Defence Minister of Russia, Sergei Shoigu, said on 27 November 2020 that Russia plans to vaccinate over 400,000 military personnel against COVID-19, as authorities reported a record 27,543 new COVID-19 cases, Reuters news agency reported on Friday.
News agencies cited Shoigu as saying that 2,500 military personnel had been vaccinated against COVID-19 already, with the total expected to reach 80,000 by the end of the year.
Russia, which is working on several vaccines against COVID-19, has reportedly seen a surge in COVID-19 infections since September 2020 but authorities have resisted imposing lockdowns, relying instead on targeted measures in certain regions.
Indian pharmaceutical company Hetero will manufacture over 100 million doses of Russia's Sputnik V COVID-19 vaccine per year under the terms of a deal with Russia's RDIF sovereign wealth fund, which was unveiled on Friday.
Siberia's Vector Institute, developing EpiVacCorona, Russia's second COVID-19 vaccine, is ready to produce up to five million doses of its vaccine per year, Alexander Ryzhikov, head of the institute's zoonotic infections and influenza department, said on Friday.
Russia, with 2,215,533 COVID-19 infections, has the fourth-largest number of COVID-19 cases in the world behind the US, India and Brazil. It has recorded 38,558 deaths related to COVID-19 since the start of the pandemic.
Piramal Pharma acquires controlling stake in Yapan Bio
Innorna Nominated for 2026 Prix Galien USA Best Startup Award
Sanofi's MenQuadfi receives EU approval for infants from six weeks
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
Northwest Biotherapeutics presents on propensity score matching at BNOS 2026
Taiwan biomedical startups hold over 100 business meetings at BIO 2026
SK bioscience to lead Gates Foundation-funded ROTOR project
Anixa Biosciences' breast cancer vaccine technology granted first Korean patent
Transgene expands myvac platform into non-small cell lung cancer with TG4070
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB
Bavarian Nordic secures DKK700m government vaccine contract
Anixa secures Canadian patent milestone for ovarian cancer vaccine
Transgene to present preclinical TG-MVA mpox vaccine data at World Congress on Infectious Diseases